Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lifecell International Pvt. |
RCV001270294 | SCV003914817 | likely pathogenic | Amelogenesis imperfecta hypomaturation type 2A2 | criteria provided, single submitter | clinical testing | A Heterozygous Missense variant c.625G>C in Exon 4 of the MMP20 gene that results in the amino acid substitution p.Glu209Gln was identified. The observed variant has a maximum allele frequency of 0.00006/% in gnomAD exomes and novel in genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic (Variant ID: 917990). Based on the above evidence this variant has been classified as Likely Pathogenic according to the ACMG guidelines. | |
Leeds Amelogenesis Imperfecta Research Group, |
RCV001270294 | SCV001338799 | pathogenic | Amelogenesis imperfecta hypomaturation type 2A2 | 2020-06-11 | no assertion criteria provided | research |